Immunic (IMUX) Current Assets (2013 - 2026)

Immunic (IMUX) has 14 years of Current Assets data on file, last reported at $188.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 894.78% year-over-year to $188.8 million; the trailing twelve-month figure through Mar 2026 stood at $188.8 million (up 894.78% YoY), and the FY2025 full-year result was $22.9 million, down 41.86% from the prior year.
• Current Assets climbed to $188.8 million in Q1 2026, from $22.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $188.8 million in Q1 2026 to a low of $19.0 million in Q1 2025.
• A 5-year average of $80.2 million and a median of $85.0 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets tumbled 81.51% in 2025 and jumped 894.78% in 2026, its largest moves.
• Tracing IMUX's Current Assets over 5 years: stood at $125.9 million in 2022, then plunged by 58.26% to $52.5 million in 2023, then declined by 25.13% to $39.3 million in 2024, then slumped by 41.86% to $22.9 million in 2025, then soared by 725.39% to $188.8 million in 2026.
• Business Quant data shows IMUX's Current Assets at $188.8 million in Q1 2026, $22.9 million in Q4 2025, and $39.3 million in Q3 2025.